Erythropoietin is increased in all of the following conditions, except:
**Core Concept**
Erythropoietin (EPO) is a hormone produced mainly by the kidneys that stimulates red blood cell production in the bone marrow. Its production is regulated by the body in response to low oxygen levels, which trigger the release of EPO to increase red blood cell production.
**Why the Correct Answer is Right**
Erythropoietin production is typically increased in conditions that lead to low oxygen levels, such as anemia, high-altitude environments, or chronic kidney disease. This is because EPO production is stimulated by the hypoxia-inducible factor (HIF) pathway, which responds to low oxygen levels by increasing EPO production. In conditions where EPO production is not appropriately increased, such as in severe kidney disease, this pathway is often disrupted.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because chronic kidney disease typically leads to increased EPO production in an attempt to compensate for the reduced kidney function and resulting anemia.
**Option B:** This option is incorrect because chronic obstructive pulmonary disease (COPD) often leads to low oxygen levels in the blood, which would result in increased EPO production.
**Option C:** This option is incorrect because liver disease can lead to increased EPO production, particularly in cases of liver cirrhosis with associated anemia.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that EPO production is primarily regulated by the kidneys, and conditions that affect kidney function, such as chronic kidney disease, can disrupt this regulatory pathway, leading to anemia and other complications.
**Correct Answer: D. Liver disease.